Insys Therapeutics, Inc. to Present at J.P. Morgan 35th Annual Healthcare Conference
January 04 2017 - 4:30PM
Insys Therapeutics, Inc. (“Insys” or “the Company”) (NASDAQ:INSY)
today announced that Santosh Vetticaden, MD, PhD, Senior Vice
President and Chief Medical Officer, and Darryl Baker, Chief
Financial Officer, will present at the J.P. Morgan 35th Annual
Healthcare Conference as follows:
Date: |
|
Monday, January 9,
2017 |
|
Time: |
|
4:00 p.m. Pacific
Standard Time |
|
Location: |
|
Westin St. Francis
Hotel, San Francisco |
|
The presentation will be webcast live at the aforementioned time
as well as archived for 90 days thereafter, via the Company’s
website at www.insysrx.com, under the Investors Section or at
http://jpmorgan.metameetings.com/confbook/healthcare17/directlink?p=22495.
About Insys Therapeutics, Inc. Insys
Therapeutics is a specialty pharmaceutical company that develops
and commercializes innovative drugs and novel drug delivery systems
of therapeutic molecules that improve the quality of life of
patients.
Investor Contact:
Lisa M. Wilson
Email: lwilson@insitecony.com
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Mar 2024 to Apr 2024
INSYS THERAPEUTICS, INC. (NASDAQ:INSY)
Historical Stock Chart
From Apr 2023 to Apr 2024